Order byBest matchMost fresh
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The mRNA-based RSV shot,
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - Fiona Havers had worked for the Centers of Disease Control for 13 years bef
CDC Virus Expert Quits With a Scary Warning After RFK Jr.’s Vaccine Panel Purge
A second senior CDC official has resigned in two weeks, citing fears that scientific integrity is being undermined under vaccine sceptic Health and Human Services Secretary Robert F. Kennedy Jr. Dr. Fiona Havers,
Devdiscourse22h
CDC Scientist Resigns Over Concerns of Data Misuse
Dr. Fiona Havers, a U.S. government scientist overseeing COVID-19 and RSV data, resigned, citing concerns over misuse of data by the Trump administration. Following Health Secretary Robert Kennedy Jr.
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects
Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The RSV shot,
Medpage Today on MSN7h
Matthew Perry's Doctor Pleads Guilty; CDC Official Resigns; $7.4B Opioid Settlement
Note that some links may require registration or subscription. A physician who supplied Matthew Perry with ketamine prior to the Friends actor's overdose last year will plead guilty to drug charges. ( AP)
FDA expands approval of Moderna's RSV vaccine to some adults under age 60
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.
FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from respiratory syncytial virus,
Zacks Investment Research on MSN1d
EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy
GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine,
Feedback